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List of Abbreviations
ATP adenosine triphosphate
Ca calcium
cAMP cyclic adenosine monophosphate
CRP C-reactive protein
DNA deoxyribonucleic acid
IFN interferon
Ig immunoglobulin
IL interleukin
K potassium
MAPK mitogen-activated protein kinase
MDA malondialdehyde
Mg magnesium
MgT total serum Mg concentrations
NADPH nicotinamide adenine dinucleotide phosphate
NFκB activation of nuclear factor-kappaB
NHANES National Health and Nutrition
NMDA N-methyl-D-aspartate
PAI plasminogen activator inhibitor
PMN polymorphonuclear
PTH parathyroid hormone
RBCs red blood cells
RDA recommended dietary allowance
RNA ribonucleic acid
ROS reactive oxygen species
TNF tumor necrosis factor
VCAM vascular cell adhesion molecule
INTRODUCTION
In recent decades the clinical relevance and biologic 
significance of magnesium (Mg) have been extensively 
documented. However, the role of Mg in medicine started 
as far back as the 17th century covering a large span of 
the chemical and pharmacologic fields of knowledge. The 
recognition by Grew, in 1695, that magnesium sulfate is 
one of the essential constituents of Epsom salt, may be 
considered the entry of magnesium into medicine.1
The Mg ion, the second most abundant intracellular cat-
ion after potassium, plays essential roles in the structure 
and function of the human body; it is an essential cofactor 
in a wide variety of biologic processes, including protein 
synthesis, nucleic acid synthesis and stability, neuromus-
cular excitability and the conduction of neural impulses, 
stimulus–contraction coupling and muscle contraction.2,3 
In particular, it is now clear that the Mg ion, although not 
directly involved in the biochemical process of contrac-
tion, modulates vascular smooth muscle tone and con-
tractility by affecting calcium ion concentrations and the 
availability of the calcium ion at critical sites. Magnesium 
serves to actively promote relaxation, offset calcium-
related excitation– contraction coupling and decrease cel-
lular responsiveness to depolarizing stimuli by different 
mechanisms: (i) stimulating Ca-dependent K channels; (ii) 
competitively inhibiting calcium (Ca) binding to calmod-
ulin; (iii) stimulating both plasma membrane and sarco-
plasmic reticulum Ca ATPases; and (iv) activating the 
membrane Na,K-ATPase pump.2,4 Magnesium is a critical 
modulator of the tension with which the contractile appa-
ratus of striated muscle responds to the prevailing ionized 
calcium concentration; the Mg complex with adenosine 
triphosphate (MgATP) is the substrate for the enzymatic 
reactions that underlie the sliding filament mechanism for 
myofibrillar contraction and relaxation. Magnesium also 
participates in many of the most vital oxidative, synthetic, 
and transport processes of the muscle cell. Consistent with 
the above, calcium-induced contraction in muscles is not 
only sensitive to changes in Mg concentration, but direct 
reduction of extracellular Mg raises smooth muscle Ca 
content, while conversely, elevations in Mg concentrations 
reciprocally lower calcium content in muscle.5 Magnesium 
is an indispensable part of the activated MgATP complex, 
and it is required for adenosine triphosphate (ATP) synthe-
sis in the mitochondria.2,3 Cell signaling requires MgATP 
for the phosphorylation of proteins and the synthesis and 
activation of the cell-signaling molecule cyclic adenosine 
monophosphate (cAMP), involved in multiple biochemi-
cal processes. Magnesium is a necessary cofactor in over 
300 enzymatic reactions; it is required for the activity of 
16. MAGNESIUM, OXIDATIVE STRESS, AND SARCOPENIA158
2. ANTIOXIDANTS AND AGING
all rate-limiting glycolytic enzymes, protein kinases, and, 
more generally, all ATP and phosphate transfer-associated 
enzymes. Magnesium may also bind the enzymes directly 
(i.e. RNA and DNA polymerases) and alter their struc-
ture.2,3 Therefore, the availability of an adequate quantity 
of Mg may be considered a critical factor for normal cellu-
lar and body homeostasis and function (Table 16.1).
MAGNESIUM METABOLISM IN OLDER 
ADULTS
The adult human body contains approximately 24 g (1 
mol) of Mg, of which about 65% resides in the mineral 
phase of bone, about 27% is found in muscle, and 6–7% 
is found in other cells. Extracellular Mg accounts for only 
1% or so of total body Mg. The normal serum Mg con-
centration ranges from 0.75 to 0.95 mmol/L (1.7–2.5 mg/
dL or 1.5–1.9 meq/L) and is tightly controlled and main-
tained in this range. In the serum, about 70–80% of Mg 
exists in the biologically active ionized (free) form, while 
the remainder is bound to circulating proteins (e.g. albu-
min) (20–30%) or complexed to anions (e.g. bicarbonate, 
phosphate) (1%). The cytosolic Mg concentration ranges 
between 0.5 and 1.0 mmol/L in various types of cell2,6 
(Tables 16.2 and 16.3). The magnesium status in the body 
is determined mainly by absorption through the gastro-
intestinal tract, the requirement of different tissues (i.e. 
skeletal and cardiac muscle uptake and usage), and renal 
excretion. The small intestine is the main site for Mg 
absorption. Healthy individuals need to ingest 0.15–0.2 
mmol/kg/day to stay in balance. The kidney exerts the 
most predominant impact in controlling body Mg status. 
Diuretics, frequently used in older populations, may also 
modify renal Mg handling, reducing Mg reabsorption.2,6
Bone is the main storage location of Mg, which cannot 
be quickly exchanged with the Mg in extracellular flu-
ids; more prompt requirements for Mg are satisfied from 
the Mg stored in the intracellular compartment. There is 
wide-ranging variability in Mg intake, absorption, con-
servation, and excretion. Alterations in Mg metabolism 
that have been associated with aging include a reduction 
in Mg intake and intestinal absorption, and an increase 
in Mg urinary and fecal excretion (Figure 16.1). Although 
no known hormonal factor is specifically involved in the 
regulation of Mg metabolism, several hormones are rec-
ognized to have an effect on Mg balance and transport. 
Among them, parathyroid hormone (PTH), calcitonin, 
catecholamines, and insulin have a major role.2,6
One of the main reasons why Mg metabolism has not 
become a greater focus of routine attention in clinical 
practice has been the difficulties in obtaining an easily 
available, accurate, and reproducible measurement of 
Mg status in the body. Total serum Mg concentrations 
(MgT) do not always reflect accurately the body Mg 
homeostasis; MgT has proved useful and it has been 
extensively utilized in epidemiologic studies, but it may 
not be helpful for the detection of a subclinical Mg deficit 
on an individual basis. MgT does not change with age, 
while intracellular free Mg tends to decrease with age.6 
TABLE 16.1 Physiological Role of Magnesium in the Body
ENZYME FUNCTION
Enzyme Substrate
 •  Kinases
 •  ATPases/GTPases
 •  Cyclases
Direct Enzyme Activation
 •  Phosphofructokinase
 •  Creatine kinase
 •  5-Phosphoribosyl- 
pyrophosphate synthetase
 •  Adenylate cyclase
 •  Na-K-ATPase
STRUCTURAL FUNCTION
 •  Proteins
 •  Polyribosomes
 •  Nucleic acids
 •  Multiple enzyme complexes
 •  Mitochondria
CALCIUM ANTAGONIST
 •  Muscle contraction/relaxation
 •  Neurotransmitter release
 •  Action potential  
conduction in nodal tissue
MEMBRANE FUNCTION
 •  Cell adhesion
 •  Transmembrane electrolyte flux
TABLE 16.2 Characteristics of Ionic Magnesium
Element category Alkaline earth metal
Atomic number 12
Atomic weight 24.305 g/mol
Valence 2
Normal serum 0.75-0.95 mmol/L
1.7-2.5 mg/dL
Total body content 24 g
Distribution in serum  –  free ionized 70-80%
 –  protein-bound 20-30%
 –  complexed 1%
TABLE 16.3 Magnesium Equilibrium
 •  Main determinants are gastrointestinal absorption and renal 
excretion
 •  Healthy individuals need to ingest 0.2-0.4 mmol/kg of body 
weight/day to stay in balance
 •  Extracellular Mg is in equilibrium with that in the bone, kidneys, 
intestine, and other soft tissues
 •  Bone is the main reservoir of Mg
 •  Primary renal disorders cause hypomagnesemia by decreased 
tubular reabsorption of Mg
 •  Osmotic diuresis results in magnesium loss
 •  Drugs may cause magnesium wasting
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However, more precise and expensive techniques for 
measuring intracellular free Mg concentrations remain 
mainly at the research level, while available measure-
ments of serum ionized free Mg, the active part of serum 
Mg, may still have some technical flaws.2,6
Aging represents a major risk factor for Mg deficit. 
The total body Mg content and intracellular Mg tend 
to decrease with age.2 The most common mechanisms 
which may cause Mg deficits with aging are summa-
rized in Table 16.4;6 they include primary Mg deficit 
(inadequate Mg nutrient intake, reduced efficiency of 
Mg absorption, and increased urinary excretion of Mg), 
and secondary Mg deficiency (associated with drug use 
or pathologic conditions associated with aging).
MAGNESIUM, MUSCULAR 
PERFORMANCE, AND AGING MUSCLE
An adequate cellular Mg concentration seems necessary 
for maintaining optimal muscle performance and exer-
cise tolerance. Magnesium status strongly affects muscle 
performance, probably due to the key role of magnesium in 
energetic metabolism, transmembrane transport, and mus-
cle contraction and relaxation.7 Magnesium is involved in 
numerous processes that affect muscle function, includ-
ing oxygen uptake and energy production. Myofibrillar 
contraction and relaxation is strictly connected to Mg and 
MgATP, as is the uptake and release of Ca from the sar-
cotubules. Thus, intracellular concentrations of Mg, even 
within narrow limits, can profoundly affect the contractile 
performance of the muscle cell (Table 16.5).
Magnesium supplementation (up to 8 mg/kg daily) 
was shown to enhance muscle strength (20% increase 
of peak knee-extension torque) in young individu-
als,8 improve endurance exercise performance, and 
decrease oxygen use during submaximal exercise.9 
Exercise induces a redistribution of Mg in the body to 
accommodate metabolic needs, accounting for changes 
in Mg concentration in extracellular fluids, blood cel-
lular components, myocytes, and adipocytes. It has 
been suggested that Mg deficiency may impair exercise 
performance and increase the oxidative stress linked 
to strenuous exercise.10 Conversely, exercise increases 
urinary and sweat losses of magnesium, and thus the 
Mg requirement is increased in an individual perform-
ing exercise. A low Mg intake in athletes may result in 
a Mg-deficient status, and may thus reduce their per-
formance. Magnesium supplementation, or increased 
dietary intake, is beneficial to physically active persons 
with a low or deficient Mg status to enhance strength 
TABLE 16.4 Main Mechanisms of Magnesium deficit with Aging
PRIMARY MAGNESIUM DEFICIT
 •  Inadequate Mg dietary intake
 •  Reduced efficiency of Mg absorption (associated with reduced 
vitamin D levels)
 •  Increased urinary excretion of Mg (associated with age-
dependent reduction of kidney function and of Mg tubular 
reabsorption)
SECONDARY MAGNESIUM DEFICIENCY
 •  Associated with age-related diseases and comorbidities
 •  Increased urinary Mg loss secondary to drugs (i.e. diuretics) 
frequently used in older persons
FIGURE 16.1 Magnesium homeostasis with age (arrows 
indicate possible sites of alteration with aging).
Urinary excretion
5 mmol/die
Fecal excretion
7.5 mmol/die
80%
absorption
25-60%
INTERSTITIAL FLUIDS
7 mmol
Plasma 2.5 mmol
60%
Total Body Mg 
24-29 g
Bone
600-700 
mmol
Diet
12.5 mmol/day
Intracellular
Compartment
TABLE 16.5 Mechanisms by Which low Magnesium Status May 
Affect Muscle, Increasing Oxidative Stress
 •  Energetic metabolism (oxygen uptake and energy production)
 •  Transmembrane transport
 •  Muscle contraction and relaxation (by means of MgATP and the 
release of calcium)
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and to improve exercise performance.8,9 There is less evi-
dence for Mg supplementation in physically active per-
sons with an adequate Mg status for enhancing physical 
performance.10
A large portion of the energy used for physiologic 
functions in humans is produced by mitochondria 
through the movement of electrons in the respiratory 
chain. Magnesium in the mitochondria accounts for one 
third of total cellular Mg; it is present as a complex with 
ATP and as a component of membranes and nucleic 
acids. Magnesium is critical for basic mitochondrial 
functions, including ATP synthesis, electron transport 
chain complex subunits, and oxygen detoxification.2,6 
As discussed below, Mg seems fundamental for con-
trolling oxidative stress and for the preservation of nor-
mally functioning muscle mitochondria. An inadequate 
availability of Mg may lead to reduced mitochondrial 
efficiency and increased production of reactive oxygen 
species (ROS), and subsequent structural and functional 
impairment of proteins that may lead to the decline in 
skeletal muscle mitochondrial function associated with 
aging in humans.11
In rats, Mg depletion is associated with structural 
damage to muscle cells, mitochondrial swelling and an 
altered ultrastructure that was shown to be associated 
with an increased production of ROS, lipid and protein 
damage, and impaired intracellular calcium homeostasis. 
Both Mg deficit and exercise contribute to the occurrence 
of oxidative stress.12 Although the importance of Mg as a 
determinant of muscle performance in young athletes is 
well established, its role in maintaining muscle integrity 
and function in older adults is largely unknown.
Lukaski and Nielsen7 examined the effects of differ-
ent levels of dietary Mg on biochemical measures and 
physiologic responses in postmenopausal women (45 
to 71 years old) during submaximal exercise, in rela-
tion to changes in erythrocyte and skeletal muscle Mg 
concentrations. The women consumed diets containing 
conventional foods with varying Mg content, totaling 
112 mg/8.4 MJ (2000 kcal) supplemented with 200 mg 
of Mg daily for 35 days (control), then 112 mg/8.4 MJ for 
93 days (depletion) followed by 112 mg/8.4 MJ supple-
mented with 200 mg of Mg daily for 49 days (repletion), 
in a depletion–repletion experiment. The concentration 
of Mg in erythrocytes, Mg retention, and skeletal muscle 
Mg content decreased when dietary Mg was restricted. 
Peak oxygen uptake, total and cumulative net oxygen 
uptake – determined by using indirect calorimetry – 
and peak heart rate increased during standardized sub-
maximal work with restricted compared with adequate 
dietary Mg.7 These findings indicate that dietary Mg 
depletion, in otherwise healthy women, results in a sig-
nificant increase in energy needs and adversely affects 
cardiovascular function during sub-maximal work. 
These data, showing a decreased work economy and 
functional impairment in older women on restricted 
dietary Mg, extend the knowledge of magnesium status 
in young athletes to older women not participating in 
intense physical activity.
Older age is frequently characterized by sarcopenia, 
defined as a loss of skeletal muscle mass, quality, and 
function.13 Sarcopenia of aging is almost a universal phe-
nomenon, occurring in a wide range of species, from nema-
todes to flies, rodents, non-human primates, and humans. 
Muscle changes in humans start in the fourth decade of 
life. Sarcopenia in the aging population is a strong inde-
pendent risk factor for disability and mortality. What 
gererally occurs with aging is a decrease in the rate of 
synthesis of several muscle proteins, specifically myosin 
heavy chain and mitochondrial proteins. The underlying 
causes of the reduction in mitochondrial activity and ATP 
production seem to be related to a decrease in mitochon-
drial DNA and in messenger RNA. Reduced ATP produc-
tion has been suggested to be the basis of reduced muscle 
protein turnover, which requires energy13 (Table 16.6). 
Magnesium depletion, because of the fundamental 
role of Mg in the MgATP complex, may play a role in 
this phenomenon, causing structural damage in muscle 
cells through increased oxidative stress (see below) and 
impaired intracellular calcium homeostasis. Both aerobic 
exercise and resistance exercise enhance muscle protein 
synthesis and mitochondrial activity. We do not know the 
role of Mg in aging-related muscle mitochondrial dys-
function, or the role of reduced physical activity. Because 
Mg status is strictly related to muscle ATP, and both Mg 
deficiency and sarcopenia tend to be more prevalent at 
older ages, we hypothesized that poor Mg status contrib-
utes to late life sarcopenia. Using data from the InCHI-
ANTI study, a well-characterized representative sample 
of older men and women, we found a significant, inde-
pendent, and strong relationship between circulating Mg 
and muscle performance; this was consistent across sev-
eral muscle performance parameters for both men and 
women,14 suggesting a role for Mg status in helping to 
maintain muscle function with age. As discussed below, 
in addition to the role of Mg in energetic metabolism, at 
least two other mechanisms may help to explain these 
findings: (i) increased oxidative stress in the presence of 
Mg deficiency, and (ii) the proinflammatory effect of Mg 
depletion.
TABLE 16.6 Effects of Aging on the Mitochondria by Which 
Oxidative Stress May Be Increased
 •  Decreased number
 •  Morphology modifications
 •  Increased DNA mutations
 •  Decreased biogenesis
 •  Decreased autophagy
 •  Increased apoptosis
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MAGNESIUM, EXERCISE,  
AND OXIDATIVE STRESS
Studies on cultured cells, in experimental animal 
models, and in humans, have consistently shown that 
Mg deficiency is associated with increased oxidative 
stress and decreased antioxidant defense. Several stud-
ies have shown convincingly that Mg deficiency results 
in increased production of oxygen-derived free radicals 
in various tissues, increased free-radical-elicited oxida-
tive tissue damage, increased production of superox-
ide anion by inflammatory cells, decreased antioxidant 
enzyme expression and activity, decreased cellular and 
tissue antioxidant levels, and increased oxygen peroxide 
production.6,15-23 Magnesium deficiency in rats causes 
decreased hepatic glutathione, superoxide dismutase, 
and vitamin E, together with increased lipid peroxida-
tion and malondialdehyde (MDA) levels secondary to 
upregulated nicotinamide adenine dinucleotide phos-
phate (NADPH) oxidase activity.24
In stroke-prone spontaneously hypertensive rats, 
Mg deficiency results in marked increases in oxidative 
stress, superoxide accumulation, mitogen-activated pro-
tein kinase (MAPK) activation, and the development of 
hypertension.25 Magnesium has antioxidant capacities 
and may prevent oxygen radical formation by scav-
enging free radicals and by inhibiting xanthine oxidase 
and NADPH oxidase.26 Magnesium supplementation 
may reduce oxidative stress. In experimental diabetes, 
a decreased intracellular Mg level and increased Mg uri-
nary excretion were associated with increased plasma 
MDA and decreased expression of hepatic superoxide 
dismutase and glutathione S-transferase; all of these 
effects were corrected by Mg supplementation.27
We have shown that antioxidant capacity and the 
action to reduce oxidative stress of glutathione and 
vitamin E (measured as decreased reduced/oxidized 
glutathione ratio, increased lipohydroperoxides, and 
increased thiobarbituric acid-reactive substances) are 
associated with an increase in the intracellular concen-
tration of Mg.28,29
MAGNESIUM, OXIDATIVE STRESS,  
AND THE AGING MUSCLE: THE ROLE  
OF INFLAMMATION
A state of chronic inflammation has been proposed 
as one of the main causes of frailty in older persons.30 
Poor Mg status may trigger the development of a pro-
inflammatory state both by causing excessive produc-
tion and release of IL-1β and TNF-α,31 and by elevating 
circulating concentrations of pro-inflammatory neuro-
peptides that trigger activation of low-grade chronic 
inflammation.32
Several interventional studies in animal models 
of Mg deficiency have provided convincing evidence 
of the link between Mg, inflammation, and oxida-
tive stress. Oxidative mitochondrial decay linked to 
aging may itself favor hypomagnesemia. Magnesium 
deficiency inhibits endothelial growth and migra-
tion, and it stimulates the synthesis of nitric oxide and 
some inflammatory markers, thus directly modulating 
microvascular functions.33,34 Experimental studies in 
rats have shown that Mg deficiency induces a chronic 
impairment of redox status associated with inflam-
mation, which could contribute to increased oxidized 
lipids, and may promote hypertension and vascular 
disorders,35 confirming the link between oxidative 
stress and inflammation.
Several other experimental studies have demon-
strated that Mg deprivation determines a pro-inflamma-
tory state, confirmed by the elevated circulating plasma 
level of several markers of inflammation, including 
interleukin-6 (IL-6), IL-1β, tumor necrosis factor (TNF)-α, 
vascular cell adhesion molecule (VCAM), and plasmino-
gen activator inhibitor (PAI)-1; other markers of inflam-
mation, such as increased circulating inflammatory cells 
and increased hepatic production and release of acute 
phase proteins (i.e. complement, alpha2-macroglobu-
lin, alpha1-acid glycoprotein, fibrinogen), have been 
reported as well.33-39 A direct mechanistic link has been 
reported for the association of low Mg and increased 
production and secretion of TNF-α and IL-1β in cultured 
alveolar macrophages.40
Because Mg acts as a natural calcium antagonist, the 
molecular basis for the inflammatory response may also 
be the result of a modulation of the intracellular calcium 
concentration. Potential mechanisms include the prim-
ing of phagocytic cells, the opening of calcium channels, 
activation of N-methyl-D-aspartate (NMDA) receptors, 
and/or the activation of nuclear factor-kappaB (NFκB).2,6
Studies in humans have confirmed the clinical rel-
evance of the link between low serum Mg levels, as 
well as inadequate dietary Mg, and low-grade systemic 
inflammation.41-44 Data from the Women’s Health 
Study have shown that Mg intake is inversely related 
to systemic inflammation, measured by serum C-reac-
tive protein concentrations, and to the prevalence of 
the metabolic syndrome in adult women.41 Likewise, 
using the 1999–2002 NHANES databases, King et al 
found that dietary Mg intake was inversely related to 
C-reactive protein levels. Among the 70% of the pop-
ulation not taking supplements, Mg intake below the 
RDA was significantly associated with a higher risk 
of having elevated C-reactive protein.42 Other clinical 
studies have suggested that serum Mg levels are also 
inversely related to oxidative stress and inflamma-
tion markers, including C-reactive protein and TNF-α 
concentrations.43,44
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MAGNESIUM, IMMUNE RESPONSES,  
AND OXIDATIVE STRESS
There is evidence that Mg plays a role in the immune 
response. Magnesium has a strong relationship with 
the immune system, in both non-specific and specific 
immune responses, while magnesium deficit has been 
shown to be related to impaired cellular and humoral 
immune function. Magnesium deficiency leads to immu-
nopathologic changes that are related to the initiation of 
a sequential inflammatory response. Magnesium is a co-
factor for immunoglobulin (Ig) synthesis, immune cell 
adherence, antibody-dependent cytolysis, IgM lympho-
cyte binding, macrophage response to lymphokines, and 
T helper-β cell adherence.45,46 In addition, Mg deficiency 
seems to accelerate thymus involution. One of the most 
remarkable results regarding the effects of Mg deficiency 
on the organism is the higher level of apoptosis shown in 
thymuses from Mg-deficient rats as compared with con-
trols.47 Altered polymorphonuclear (PMN) cell number 
and function have been shown in rats fed a Mg-deficient 
diet for 8 days, together with the characteristic inflam-
matory response. In fact, an increased number of neutro-
phils, related to an increased activity of phagocytosis, has 
been found in Mg-deficient rats compared with control 
rats.48 Clinical signs of inflammation, splenomegaly, and 
leukocytosis, have been reported as well in rats given a 
Mg-deficient diet. A reduced proportion of CD8-T cells 
has been shown under these conditions, which has been 
related to a decreased concentration of interferon (IFN)-γ 
in spleen homogenates.49 Several changes in gene expres-
sion, including upregulation of TNF receptor 1 and IL-1 
receptor type I, have also been demonstrated in rat thymo-
cytes in early Mg deficiency.21 A recent study discovered 
a key role for Mg in the T cell antigen receptor signaling 
pathway from the study of a novel primary immunode-
ficiency.50 There are studies confirming the involvement 
of Mg in human cell apoptosis. Fas-induced β-cell apop-
tosis is Mg-dependent. Increased cytosolic free Mg lev-
els are required for Fas molecule binding expression on 
the β-cell surface to initiate multiple signaling pathways 
that result in apoptotic cell death.51 In vitro incubation of 
granulocytes in media with different Mg composition 
resulted in significant changes in chemotactic peptide-
induced calcium transients.52
Because physical exercise may deplete Mg, many 
aspects of immune function can be depressed temporar-
ily by either severe exercise or a longer period of exces-
sive training.53 Although the disturbance is usually quite 
transient, it has been suggested that it may be sufficient 
to allow clinical episodes of infection, particularly upper 
respiratory tract infections.53 The risk may be higher 
in older persons who already have a reduced immune 
capacity and a consequent propensity to infections. How-
ever, regular and moderate exercise has been reported to 
improve the ability of the immune system to protect the 
host from infection.53 Strenous exercise has been associ-
ated with an acute increase in oxidative stress free radical 
(ROS) production.13 ROS may contribute to the develop-
ment of muscle fatigue in situ, but there is still a lack of 
convincing direct evidence that ROS are able to impair 
exercise performance in vivo in humans. It remains 
unclear whether exercise-induced oxidative stress modi-
fications may have clinical significance. Conversely, the 
antioxidant actions of Mg26 may have a role in muscle 
protection in the aging population. Even though this 
needs to be proven by specific trials, it is likely that main-
taining a good quality Mg homeostasis throughout life, 
and in particular in older persons, may help to protect 
from muscle performance decline associated with aging.
CONSEQUENCES OF MAGNESIUM 
IMBALANCE WITH AGE
The consequences of Mg imbalance in elderly people 
related to defective membrane function, chronic inflam-
mation, increased oxidative stress, and immune dysfunc-
tion may include an increased vulnerability to age-related 
diseases and particularly to sarcopenia and frailty.
Several studies have reported alterations in cell physi-
ology with senescence features during Mg deficiency in 
different cell types. Magnesium is an essential cofactor 
in cell proliferation and differentiation and in all steps 
of nucleotide excision repair. Magnesium deficiency-
related alterations may include reduced oxidative stress 
defense, cell cycle progression, culture growth, cel-
lular viability,54-57 activation of proto-oncogenes (i.e. 
c-fos, c-jun), and expression of transcription factors (e.g. 
NFκB).58 Magnesium deficiency may accelerate cellular 
senescence in cultured human fibroblasts. Continuous 
culture of primary fibroblasts in Mg-deficient media 
resulted in the loss of replicative capacity with acceler-
ated expression of senescence-associated biomarkers. 
A marked decrease in the replicative lifespan was seen 
compared to fibroblast populations cultured in standard 
Mg media conditions. Human fibroblast populations 
cultured in Mg-deficient conditions also showed an 
increased senescence-associated β-galactosidase activity. 
Additionally, activation of cellular aging (p53 and pRb) 
pathways by Mg-deficient conditions also increased the 
expression of proteins associated with cellular senes-
cence, including p16INK4a and p21WAF1. Telomere 
attrition was found to be accelerated in cellular popu-
lations from Mg-deficient cultures, suggesting that the 
long-term consequence of inadequate Mg availability 
in human fibroblast cultures is an accelerated cellular 
senescence.59 Features of cellular senescence induced by 
low magnesium concentrations have also been reported 
in other cell types, e.g. endothelial cells.60 Intracellular 
free Mg is a ‘second messenger’ for downstream events 
in apoptosis. There is increasing evidence from animal 
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experiments and epidemiologic studies that Mg defi-
ciency may decrease membrane integrity and membrane 
function, increasing the susceptibility to oxidative stress, 
cardiovascular disease, and accelerated aging. It is likely 
that many of these Mg effects may have relevance also to 
the aging of muscle and sarcopenia, as well as to many 
other age-related diseases.
CONCLUSIONS
Aging is very often associated with Mg inadequacy. 
Chronic Mg deficiency may result in excessive produc-
tion of oxygen-derived free radicals. Oxidative stress 
and a chronic, low-grade inflammation have been pro-
posed as an underlying condition linked to aging mus-
cle, sarcopenia, and frailty. A chronic Mg deficit has been 
proposed as one of the physiopathologic mechanisms 
that may help to explain the interactions among inflam-
mation and oxidative stress with sarcopenia, frailty, and 
a number of age-related diseases (Figs 16.2 and 16.3).
Magnesium status is strictly connected to muscle per-
formance in older persons. A possible mechanism of this 
association is the effect of Mg concentrations on mito-
chondrial function in muscle, which may be particularly 
critical in the aging muscle.
Despite the physiologic importance of Mg, the mul-
tiple problems associated with its deficiency, and the 
ease of supplementation, inadequate Mg intake remains 
highly prevalent in various populations. Because Mg 
supplementation is inexpensive and in general well tol-
erated, it should be a key consideration in older subjects 
at particular risk for Mg deficiency. Although existing 
data confirm that the availability of an adequate quan-
tity of Mg is a critical factor for normal cellular and body 
homeostasis, much remains to be done in this field to 
further clarify the potential role of Mg supplementation.
Even if the role of Mg supplementation as a possible 
intervention approach for delaying or preventing muscle 
aging deserves some consideration, a number of ques-
tions still need to be answered. What is the role of oxida-
tive stress and inflammatory cytokines in mediating the 
adverse effect of Mg deficiency on muscle? Is low Mg a 
component of the frailty syndrome leading to sarcope-
nia of aging? Can Mg supplementation influence muscle 
strength/performance and cytokine concentrations in 
older persons? The possible role of Mg supplementation 
in aging-associated conditions remains unclear. At pres-
ent, there are no data to support a potential role of dietary 
Mg supplementation as a possible health strategy in the 
aging population. Very few open and double-blind stud-
ies on the effects of the treatment of Mg deficiencies in 
geriatric populations have been done. The possibility 
that maintaining an optimal Mg balance throughout life 
might help in preventing or significantly retarding the 
oxidative stress and inflammation process, and the man-
ifestations of chronic diseases, including sarcopenia and 
frailty, is a working hypothesis that needs to be tested in 
future prospective studies.
SUMMARY POINTS
 •  Mg is a key intracellular cation because it is an 
essential cofactor in a wide variety of biologic 
processes, including protein synthesis, nucleic acid 
synthesis and stability, neuromuscular excitability 
and conduction of neural impulses, stimulus–
contraction coupling, and muscle contraction; it is 
also an antioxidant.
FIGURE 16.2 Overall hypothesis in which a chronic 
Mg deficit has been proposed as one of the physio-
pathologic links that may help to explain the interac-
tions among inflammation, oxidative stress, and altered 
immune responses with sarcopenia of aging and with the 
aging process.
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 •  Aging is frequently associated with a Mg deficit due to 
dietary reduced intake and/or absorption, increased 
renal wasting and/or reduced tubular reabsorption, 
age-related diseases, and/or drugs, leading to 
increased oxidative stress and chronic inflammation.
 •  Magnesium status affects muscle performance, 
probably due to the key role of magnesium in 
energetic metabolism, transmembrane transport, and 
muscle contraction and relaxation. Magnesium is 
integral to the function of ATP.
 •  Aging is associated with sarcopenia, defined as the 
loss of skeletal muscle mass, quality, and function. 
Sarcopenia of aging is a strong independent risk 
factor for disability and mortality.
 •  Oxidative stress and chronic, low-grade inflammation 
have been proposed as an underlying condition linked 
to aging muscle, sarcopeni, and frailty.
 •  Magnesium acts as an antioxidant against free 
radical damage of the mitochondria. Chronic Mg 
deficiency results in excessive production of oxygen-
derived free radicals and low-grade inflammation.
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